Dose Response Trial of Pergolide for Cocaine Dependence – 1

Overview

The purpose of this study is to evaluate the efficacy and safety of pergolide for treatment of cocaine dependence.

Full Title of Study: “Dose Response Trial of Pergolide for Cocaine Dependence”

Study Type

  • Study Type: Interventional
  • Study Design
    • Primary Purpose: Treatment

Interventions

  • Drug: Pergolide

Clinical Trial Outcome Measures

Primary Measures

  • Side effects
  • Drug use
  • Retention
  • Cocaine withdrawal
  • Compliance
  • Effectiveness of medication for global improvements

Participating in This Clinical Trial

Please contact site for information.

Gender Eligibility: All

Minimum Age: 21 Years

Maximum Age: 50 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Medical University of South Carolina
  • Collaborator
    • National Institute on Drug Abuse (NIDA)
  • Overall Official(s)
    • Robert Malcolm, M.D., Principal Investigator, Medical University of South Carolina

References

Malcolm R, Moore JW, Kajdasz DK, Cochrane CE. Pergolide mesylate. Adverse events occurring in the treatment of cocaine dependence. Am J Addict. 1997 Spring;6(2):117-23. doi: 10.3109/10550499709137022.

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.